
According to a report from the Financial Times, a former Citigroup currencies trader is suing the bank for at least US$112 million, alleging that the bank “framed” him to protect itself in the throes of a market manipulation scandal that eventually led to him facing the possibility of a decade in jail.
In a case with potentially profound implications for the way banks and regulators treat individuals connected to allegations of industry-wide wrongdoing, Rohan Ramchandani claims in a suit filed in New York on Wednesday, October 2, that the bank singled him out for intense scrutiny from UK and US regulators in a “secret scheme” to “dirty up” his name.
The bank “knowingly” encouraged the US Department of Justice (DOJ) to pursue an antitrust case against him “without probable cause” in an effort to shield itself from greater damage, Mr Ramchandani claims, adding that his previous boss and one of the bank’s lawyers had repeatedly asserted he had done nothing wrong.
Mr Ramchandani was acquitted at trial over the matter in late 2018, three years after Citi reached a US$1.3 billion settlement with the DOJ and the Federal Reserve.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas